Items where Kingston Author is "Modjtahedi, Helmout"

Up a level
Export as [feed] Atom [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 20.

Article

Khelwatty, Said Abdullah, Essapen, Sharadah, Bagwan, Izhar, Green, Margaret, Seddon, Alan and Modjtahedi, Helmout (2014) Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival. PloS one, 9(3), e91139. ISSN (print) 1932-6203

Modjtahedi, Helmout, Cho, Byoung Chul, Michel, Martin C and Solca, Flavio (2014) A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer. Naunyn-Schmiedeberg's archives of pharmacology, ISSN (print) 0028-1298

Modjtahedi, Helmout and Eccles, Suzanne (2014) GA201: a novel humanized and glycoengineered anti-EGFR antibody. Clinical Cancer Research, 20(4), pp. 1053-1054. ISSN (print) 1078-0432

Polycarpou, Elena, Meira, Lisiane B, Carrington, Simon, Tyrrell, Elizabeth, Modjtahedi, Helmout and Carew, Mark A (2013) Resveratrol 3-O-d-glucuronide and resveratrol 4'-O-d-glucuronide inhibit colon cancer cell growth: Evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Molecular Nutrition and Food Research, 57(10), pp. 1708-1717. ISSN (print) 1613-4125

Ioannou, Nikolaos, Seddon, Alan M., Dalgleish, Angus, Mackintosh, David and Modjtahedi, Helmout (2013) Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells. BMC Cancer, 13(41), ISSN (print) 1471-2407

Modjtahedi, Helmout, Ioannou, Nikolaos, Dalgleish, Angus, Mackintosh, David and Seddon, Alan M. (2013) Co-targeting of HER family members and IGF-IR in pancreatic cancer. International Journal Of Molecular Medicine, 32, S40-S40. ISSN (print) 1107-3756

Khelwatty, Said Abdullah, Essapen, Sharadah, Seddon, Alan Michael and Modjtahedi, Helmout (2013) Prognostic significance and targeting of HER family in colorectal cancer. Frontiers in Bioscience, 18(2), pp. 394-421. ISSN (print) 1093-9946

Modjtahedi, Helmout, Ali, Sumaira and Essapen, Sharadah (2012) Therapeutic application of monoclonal antibodies in cancer: advances and challenges. British Medical Bulletin, 104(1), pp. 41-59. ISSN (print) 0007-1420

Modjtahedi, H., Khelwatty, S.A., Kirk, R.S., Seddon, A.M., Essapen, S., Del Vecchio, C.A., Wong, A.J. and Eccles, S. (2012) Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10. British Journal of Cancer, 106, pp. 883-888. ISSN (print) 0007-0920

Ioannou, N., Seddon, A.M., Dalgleish, A., Mackintosh, D. and Modjtahedi, H. (2012) Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer. Frontiers in Bioscience, 17(1), pp. 2698-2724. ISSN (print) 1093-9946

Ioannou, N, Dalgleish, A G, Seddon, A M, Mackintosh, D, Guertler, U, Solca, F and Modjtahedi, H (2011) Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. British Journal of Cancer, 105(10), pp. 1554-1562. ISSN (print) 0007-0920

Khelwatty, Said Abdullah, Essapen, Sharadah, Seddon, Alan M. and Modjtahedi, Helmout (2011) Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members. International Journal of Oncology, 39(2), pp. 483-491. ISSN (print) 1019-6439

Shafi, Shahida, Lamb, David, Modjtahedi, Helmout and Ferns, Gordon (2010) Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit. International Journal Of Experimental Pathology, 91(3), pp. 224-234. ISSN (print) 0959-9673

Modjtahedi, Helmout and Essapen, Sharadah (2009) Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. Anti-Cancer Drugs, 20(10), pp. 851-855. ISSN (print) 0959-4973

Cunningham, Matthew P., Thomas, Hilary, Marks, Christopher, Green, Margaret, Fan, Zhen and Modjtahedi, Helmout (2008) Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells. International Journal of Oncology, 33(5), pp. 1107-1113. ISSN (print) 1019-6439

Cunningham, Matthew P., Thomas, Hilary, Fan, Zhen and Modjtahedi, Helmout (2006) Responses of human colorectal tumor cells to treatment with the anti–epidermal growth factor receptor monoclonal antibody ICR62 used alone and in combination with the EGFR tyrosine kinase inhibitor gefitinib. Cancer Research, 66(15), pp. 7708-7715. ISSN (print) 0008-5472

Cunningham, Matthew P., Essapen, Sharadah, Thomas, Hilary, Green, Margaret, Lovell, David P., Topham, Clare, Marks, Christopher and Modjtahedi, Helmout (2005) Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer. International Journal of Oncology, 27(2), pp. 317-325. ISSN (print) 1019-6439

Essapen, Sharadah, Thomas, Hilary, Green, Margaret, De Vries, Corrine, Cook, Martin G., Marks, Christopher, Topham, Clare and Modjtahedi, Helmout (2004) The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathalogical parameters. International Journal of Oncology, 24(2), pp. 241-248. ISSN (print) 1019-6439

Modjtahedi, Helmout, Moscatello, David K., Box, Gary, Green, Margaret, Shotton, Christine, Lamb, David J., Reynolds, Lesley J., Wong, Albert J., Dean, Christopher, Thomas, Hilary and Eccles, Suzanne (2003) Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy. International Journal of Cancer, 105(2), pp. 273-280. ISSN (print) 0020-7136

Conference or Workshop Item

Khelwatty, Said Abdullah, Essapen, Sharadah, Seddon, Alan M., Fan, Zhen and Modjtahedi, Helmout (2013) Acquired resistance to anti-EGFR mAb ICR62 or afatinib is accompanied by upregulation of the EGFR in colorectal cancer. In: 104th Annual Meeting of the American Association for Cancer Research; 6-10 Apr 2013, Washington, U.S.A..

This list was generated on Sat Aug 30 07:27:55 2014 BST.